BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology

  • Liansheng Zhang
  • , Yun Qian
  • , Jie Li
  • , Xuan Zhou
  • , He Xu
  • , Jie Yan
  • , Jialing Xiang
  • , Xiang Yuan
  • , Beicheng Sun
  • , Sangram S. Sisodia
  • , Yong Hui Jiang
  • , Xiaohua Cao
  • , Naihe Jing*
  • , Anning Lin*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Alzheimer's disease (AD) is the most common progressive neurodegenerative disease. However, the underlying molecular mechanism is incompletely understood. Here we report that the pro-apoptotic protein BAD as a key regulator for neuronal apoptosis, neuroinflammation and Aβ clearance in AD. BAD pro-apoptotic activity is significantly increased in neurons of AD patients and 5XFAD mice. Conversely, genetic disruption of Bad alleles restores spatial learning and memory deficits in 5XFAD mice. Mechanistically, phosphorylation and inactivation of BAD by neurotropic factor-activated Akt is abrogated in neurons under AD condition. Through reactive oxygen species (ROS)-oxidized mitochondrial DNA (mtDNA) axis, BAD also promotes microglial NLRP3 inflammasome activation, thereby skewing microglia toward neuroinflammatory microglia to inhibit microglial phagocytosis of Aβ in AD mice. Our results support a model in which BAD contributes to AD pathologies by driving neuronal apoptosis and neuroinflammation but suppressing microglial phagocytosis of Aβ, suggesting that BAD is a potential therapeutic target for AD.

Original languageEnglish
Article number102942
JournaliScience
Volume24
Issue number9
DOIs
StatePublished - 24 Sep 2021
Externally publishedYes

Keywords

  • Molecular biology
  • Molecular neuroscience
  • Neuroscience

Fingerprint

Dive into the research topics of 'BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology'. Together they form a unique fingerprint.

Cite this